The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging
- 14 December 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 42 (3) , 292-299
Abstract
Introduction: This study characterizes the spectrum of physiologic 124I uptake of the lacrimal system in patients with a history of differentiated thyroid cancer (DTC) who underwent multi-timepoint 124I PET/CT imaging. Methods: 124I PET/CT in 31 DTC patients was performed at 2, 24, 48, 72, and 96 h after oral administration of 31.5 or 62.9 MBq (0.85 or 1.7 mCi) of 124I after either recombinant human thyroid-stimulating hormone injections or thyroid hormone withdrawal. All but two patients had a history of prior 131I therapy. Patterns of 124I uptake in the lacrimal glands and nasolacrimal sac/ducts (NLD) were assessed. Results: A total of 173 individual 124I PET/CT scans (forming 35 sets of scans) were reviewed for 31 patients. Lacrimal glands were visualized bilaterally in only 4 patients. The focal mild uptake (grade 2), best seen on the 2-h images, was crescent-shaped and located in the lateral upper quadrant of the orbit. In contrast, the NLDs were identified in all patients (bilateral in 29 of 31 patients) with high focal uptake (grade 4) peaking on the 2- and 24-h timepoints; however, the overall pattern of uptake was variable. Of the 29 patients with prior 131I therapy, three patients had a relatively fixed and unchanging pattern of uptake on at least one side of the NLDs. Conclusions: In patients with DTC, 124I activity in the NLDs is more frequently visualized, more intense, more prolonged, and more variable than in the lacrimal glands. The lack of clearance may suggest possible obstruction or stasis of an NLD.Keywords
This publication has 17 references indexed in Scilit:
- Nasal Symptoms After Radioiodine Therapy: A Rarely Described Side Effect with Similar Frequency to Lacrimal DysfunctionThyroid®, 2014
- Changes in conjunctival cytology and tear function tests with radioiodine treatment for hyperthyroidismAnnals of Nuclear Medicine, 2013
- Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in the Identification of Metastasis in Differentiated Thyroid Cancer with 131I Planar Whole-Body Imaging and 124I PETJournal of Nuclear Medicine, 2012
- 124 I Positron Emission Tomography Versus 131 I Planar Imaging in the Identification of Residual Thyroid Tissue and/or Metastasis in Patients Who Have Well-Differentiated Thyroid CancerThyroid®, 2010
- The Effect of High-Dose Radioiodine Treatment on Lacrimal Gland Function in Patients With Differentiated Thyroid CarcinomaClinical Nuclear Medicine, 2007
- Nasolacrimal Drainage System Obstruction from Radioactive Iodine Therapy for Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2002
- Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Lacrimal scintigraphy. I. Compartmental analysis of data.British Journal of Ophthalmology, 1983
- Lacrimal scintigraphy. III. Physiological aspects of lacrimal drainage.British Journal of Ophthalmology, 1983
- Lacrimal scintigraphy. II. Its role in the diagnosis of epiphora.British Journal of Ophthalmology, 1983